Medical Marijuana (MJNA) and CannaVest led the A round.

KannaLife Sciences, a US-based medical company developing drugs from plants such as hemp, has raised $1.5m in its series A round from two corporations.

Medical Marijuana (MJNA) and CannaVest led the A round. The investment follows a deal earlier in the month for CannaVest to buy MJNA’s PhytoSphere assets for $35m of its shares.

KannaLife holds an exclusive license with US government’s National Institutes of Health – Office of Technology Transfer (NIH) for the commercialization of US patent 6,630,507, “Cannabinoids…